Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShort-Term Debt issuances
Growth Metrics
Income Statement
Others
Ratios

Bristol Myers Squibb (BMYMP) Share-based Compensation (2016 - 2025)

Bristol Myers Squibb (BMYMP) has disclosed Share-based Compensation for 17 consecutive years, with $133.0 million as the latest value for Q4 2025.

  • Quarterly Share-based Compensation rose 10.83% to $133.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $553.0 million through Dec 2025, up 9.07% year-over-year, with the annual reading at $553.0 million for FY2025, 9.07% up from the prior year.
  • Share-based Compensation for Q4 2025 was $133.0 million at Bristol Myers Squibb, down from $139.0 million in the prior quarter.
  • The five-year high for Share-based Compensation was $157.0 million in Q2 2021, with the low at $107.0 million in Q1 2022.
  • Average Share-based Compensation over 5 years is $130.9 million, with a median of $132.5 million recorded in 2021.
  • The sharpest move saw Share-based Compensation dropped 29.14% in 2022, then rose 18.1% in 2023.
  • Over 5 years, Share-based Compensation stood at $133.0 million in 2021, then dropped by 10.53% to $119.0 million in 2022, then grew by 6.72% to $127.0 million in 2023, then dropped by 5.51% to $120.0 million in 2024, then grew by 10.83% to $133.0 million in 2025.
  • According to Business Quant data, Share-based Compensation over the past three periods came in at $133.0 million, $139.0 million, and $137.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.